American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,611 | 52,892 | 95,106 | 94,425 | 70,637 |
| Receivables | 45,544 | 71,350 | 119,023 | 57,505 | 36,982 |
| Inventories | 20,571 | 18,890 | 12,475 | 10,016 | 13,042 |
| Income taxes - deferred | 29 | 3,226 | 650 | 825 | 347 |
| Other current assets | 15,694 | 49,553 | 17,376 | 15,148 | 11,444 |
| TOTAL | $95,449 | $195,911 | $244,629 | $177,917 | $132,452 |
| Non-Current Assets | |||||
| PPE Net | 171,381 | 170,535 | 132,064 | 95,468 | 98,154 |
| Investments And Advances | 3,338 | 5,934 | 19,179 | 57,326 | 54,963 |
| Intangibles | 158,431 | 168,657 | 203,487 | 205,464 | 205,843 |
| Other Non-Current Assets | 17,710 | 23,945 | 10,865 | 40,307 | 37,263 |
| TOTAL | $350,860 | $369,071 | $365,595 | $398,565 | $396,224 |
| Total Assets | $446,309 | $564,981 | $610,223 | $576,482 | $528,676 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 65 | 63 | 61 | 60 | 59 |
| Accounts payable and accrued liabilities | 27,345 | 43,287 | 35,040 | 29,818 | 32,055 |
| Accrued Expenses | 11,016 | 8,849 | N/A | N/A | N/A |
| Other current liabilities | N/A | N/A | N/A | 2,199 | 2,253 |
| TOTAL | $106,212 | $168,628 | $44,077 | $46,974 | $45,369 |
| Non-Current Liabilities | |||||
| Long Term Debt | 555 | 618 | N/A | 744 | 1,074 |
| Other Non-Current Liabilities | 12 | 1,041 | 121,084 | 117,865 | 114,972 |
| TOTAL | $12,511 | $15,191 | $137,573 | $134,452 | $133,710 |
| Total Liabilities | $118,722 | $183,819 | $181,650 | $181,426 | $179,079 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73 | 73 | 79 | 78 | 78 |
| Common Shares | 524 | 370 | 429 | 466 | 455 |
| Retained earnings | 78,098 | 137,811 | 205,261 | 191,174 | 149,753 |
| Other shareholders' equity | 71,990 | 37,388 | 19,560 | 3,585 | 2,342 |
| TOTAL | $327,587 | $381,162 | $428,573 | $395,056 | $349,597 |
| Total Liabilities And Equity | $446,309 | $564,981 | $610,223 | $576,482 | $528,676 |